Aurinia Pharmaceuticals Quarterly Balance Sheet
NASDAQ: AUPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Aurinia Pharmaceuticals financial position
As of Jun 30, 2026, Aurinia Pharmaceuticals reported total assets of $792.3 million, up 57.6% from a year earlier against total liabilities of $177.4 million. Shareholders' equity stood at $614.9 million, or 77.6% of assets. The company held $179.7 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 5.42, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Aurinia Pharmaceuticals balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 179.73M | 40.75M | 80.16M | 72.89M | 52.91M | 66.11M | 83.40M | 36.63M | 33.27M | 63.91M | 48.76M | 45.56M |
| Inventory | 45.15M | 46.41M | 45.69M | 44.79M | 46.50M | 46.20M | 39.23M | 38.71M | 38.85M | 39.76M | 39.70M | 32.82M |
| Total Current Assets | 541.32M | 480.24M | 491.97M | 438.74M | 408.97M | 405.76M | 446.60M | 440.46M | 409.67M | 398.22M | 424.80M | 426.47M |
| Property, Plant & Equipment | 1.86M | 1.99M | 2.11M | 2.27M | 2.42M | 2.58M | 2.73M | 2.89M | 3.04M | 3.20M | 3.35M | 3.50M |
| Intangible Assets | 3.38M | 3.59M | 3.76M | 3.90M | 4.05M | 4.16M | 4.36M | 4.51M | 4.62M | 4.76M | 4.98M | 5.26M |
| Total Assets | 792.26M | 724.00M | 751.59M | 527.53M | 502.56M | 504.85M | 550.64M | 549.36M | 523.53M | 516.63M | 548.06M | 555.01M |
| Accounts Payable | 1.74M | 2.66M | 3.31M | 2.21M | 3.31M | 4.22M | 5.19M | 8.88M | 8.41M | 5.67M | 4.33M | 8.85M |
| Total Current Liabilities | 99.89M | 86.56M | 93.72M | 76.22M | 78.27M | 68.41M | 97.76M | 78.61M | 76.90M | 71.05M | 77.19M | 73.89M |
| Total Liabilities | 177.40M | 156.37M | 170.26M | 161.76M | 167.26M | 154.66M | 173.17M | 161.36M | 158.91M | 157.16M | 170.11M | 163.14M |
| Shareholders' Equity | 614.86M | 567.63M | 581.33M | 365.77M | 335.30M | 350.19M | 377.48M | 388.00M | 364.62M | 359.48M | 377.95M | 391.88M |
| Retained Earnings | -577.60M | -615.01M | -649.37M | -860.16M | -891.71M | -913.23M | -936.57M | -938.00M | -952.35M | -953.07M | -942.32M | -915.45M |
| Net Cash (Debt) | 179.73M | 40.75M | 80.16M | 72.89M | 52.91M | 66.11M | 83.40M | 36.63M | 33.27M | 63.91M | 48.76M | 45.56M |
| Shares Outstanding | 132.91M | 130.77M | 132.32M | 131.84M | 132.67M | 137.75M | 140.88M | 143.11M | 142.98M | 143.69M | 143.83M | 143.60M |
This table shows 12 quarterly periods of Aurinia Pharmaceuticals's balance sheet, from Q2 2026 back to Q3 2023, across 14 line items including cash & equivalents, short-term investments, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow AUPH's reporting calendar. What is a balance sheet?